Stay updated on Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedThe study record history shows a new revision, v3.6.6, superseding the previous v3.6.5. This indicates the record was updated to a newer version.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history, and the previous revision v3.6.4 was removed. This reflects an update to the record's version history rather than changes to the study content or data.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, reflecting an update to the record. The previous revision v3.6.3 is removed from the visible history.SummaryDifference0.1%

- Check65 days agoChange DetectedThe study record history now shows a new revision entry (v3.6.3) and removes the previous revision (v3.6.1), indicating an update to the page's version history.SummaryDifference0.1%

- Check72 days agoChange DetectedThe study record history now includes a new revision entry (v3.6.1), updating the version history. This replaces the previous v3.6.0 entry.SummaryDifference0.1%

- Check88 days agoChange DetectedA new revision entry v3.5.5 was added to the history and the previous v3.5.4 entry was removed. This reflects an update to the page's revision record.SummaryDifference0.1%

Stay in the know with updates to Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.